News Daily News Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm L.A. McKeown January 25, 2022
News Daily News DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis L.A. McKeown January 20, 2022
News Daily News Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark Caitlin E. Cox January 14, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk Todd Neale December 22, 2021
Presentation Controversies and Advances 2021 Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome Presenter: P. K. Shah December 03, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021